Assessing and Implementing Non-Prescription Treatments for Major Depressive Disorder

Simple item record
dc.contributor.authorCrawford, Rachel
dc.date.accessioned2021-07-14T19:08:34Z
dc.date.available2021-07-14T19:08:34Z
dc.date.created2020
dc.description2020 Celebration of Student Research and Creativity presentationen_US
dc.description.abstractMajor Depressive Disorder is a mental health disorder that is classified as a prolonged depressed mood and loss of interest or pleasure in activities that were once enjoyed. Treatments vary per case and typically consist of a prescription drug to combat the disorder. In the US, MDD currently affects females at 8.7% and males at 5.3% (Major Depression). There are alternative treatments that could potentially aid patients. The pricing of treatment plans may be a factor in the treatment accessibility and feasibility. There’s a possibility that an increase in cognitive-behavioral therapy accessibility will lead to higher rates of MDD recovery.en_US
dc.description.urihttps://youtu.be/y6g3RfH9Swcen_US
dc.identifier.urihttp://hdl.handle.net/11216/3740
dc.language.isoen_USen_US
dc.publisherNorthern Kentucky Universityen_US
dc.relation.ispartofseriesCelebration of Student Research and Creativity;2020
dc.subjectDepressive Disorder, Majoren_US
dc.subjectTherapeuticsen_US
dc.titleAssessing and Implementing Non-Prescription Treatments for Major Depressive Disorderen_US
dc.typePresentationen_US

Files

Collections

Student Research and Creativity